EPO and perinatal asphyxia: In addition, in a phase I/II trial in newborns with HIE,[32] using a therapeutic measure of subcooling therapy combined with EPO (1000 U/kg), the children demonstrated good tolerance and produced neuroprotective plasma concentrations in vivo.